Second-Generation Weight Loss Injections: How Have GLP-1 Medications Evolved for Obesity Management?

Weight loss injections and anti-obesity medications have evolved significantly with the introduction of newer treatments targeting hormonal pathways involved in appetite and satiety. In this episode, Dr. Mohammad Khaled Youssef explains what is meant by second-generation weight loss medications, how they differ from earlier treatments, and how advances in GLP-1 medications have changed the approach to medical weight management. The episode also explores why these developments represent an important step in treating obesity as a chronic health condition that requires appropriate medical assessment, individualized treatment, and ongoing follow-up.